Metastatic breast cancer treatments have aided decline in deaths, Stanford Medicine-led study finds.

A recent study led by Stanford Medicine clinicians and biomedical data scientists has found that deaths from breast cancer have decreased by 58% between 1975 and 2019. The decline is attributed to a combination of screening mammography and improvements in treatment. The study also revealed that nearly one-third of the decrease is due to advances in treating metastatic breast cancer, a form of the disease that has spread to other areas of the body. The findings provide valuable insights for cancer researchers and highlight the need for continued efforts to improve interventions and treatments. [Extracted from the article]